Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Single Center Randomized Controlled Trial of Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer

NCT03110939 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT03110939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03110939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Single Center Randomized Controlled Trial of Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer
Lead sponsor
Henan Cancer Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
March 21, 2017
Completion date
April 5, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, hyperthermic perfusion, lung cancer